Progressive cancer targeting by programmable aptamer-tethered nanostructures.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer incidence is rising globally, necessitating advanced therapeutic strategies.
• Conventional cancer treatments like chemotherapy and radiotherapy have limitations including toxicity and poor targeting.
• There is a critical need for innovative drug delivery systems to improve cancer treatment efficacy.

Purpose of the Study:

• To review the significance of aptamer-assembled nanoconstructs for efficient cancer drug delivery.
• To discuss advancements in designing aptamer-tethered nanostructures for enhanced cancer therapy.
• To highlight aptamers as intelligent nanomaterials for targeted drug delivery.

Main Methods:

• Review of recent scientific literature on aptamer-based nanoconstructs.
• Analysis of aptamer-assembled nanostructures for drug delivery applications.
• Discussion of design principles and functional advantages of aptamer nanocarriers.

Main Results:

• Aptamer-assembled nanoconstructs demonstrate potential as multifunctional nucleic acid oligomeric nanoskeletons.
• These nanoconstructs offer advantages such as programmable design and precise adjustment for targeted drug delivery.
• Aptamer-tethered nanostructures show promise in enhancing the efficacy of cancer treatment.

Conclusions:

• Self-assembled aptamers represent intelligent nano-biomaterials for targeted drug delivery.
• Aptamer nanoconstructs possess superior stability, high specificity, and biocompatibility.
• These advanced nanomaterials are crucial for overcoming limitations in current cancer therapy.